Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Curr Opin Pediatr. 2014 Jun;26(3):320–327. doi: 10.1097/MOP.0000000000000094

Table 1.

Classification of childhood ILD

Disorders more prevalent in infancy
Category Specific Diagnoses*
Diffuse developmental disorders Acinar dysplasia
Congenital alveolar dysplasia
Alveolar-capillary dysplasia with pulmonary vein misalignment
Lung growth abnormalities Pulmonary hypoplasia
Chronic neonatal lung disease (BPD)
Associated chromosomal disorders (Trisomy 21, others)
Associated with congenital heart disease
Specific conditions of uncertain etiology Neuroendocrine cell hyperplasia of infancy (NEHI)
Pulmonary interstitial glycogenosis (PIG)
Surfactant dysfunction Mutations in SFTPB, SFTPC, ABCA3, NKX2.1/TTF1
Histology consistent with surfactant dysfunction disorder but without recognized genetic etiology
Disorders not specific to infancy
Disorders of normal host (immune-competent) Infectious/post-infectious
Aspiration
Related to environmental agents (hypersensitivity pneumonitis, toxic inhalation)
Eosinophilic pneumonia
Disorders related to systemic disease processes Immune-related disorders (SLE, polymyositis/dermatomyositis, systemic sclerosis)
Storage diseases
Sarcoidosis
Langerhans cell histiocytosis
Malignant infiltrates
Disorders of immune-compromised host Opportunistic infections
Transplantation/rejection syndromes
Disease masquerading as ILDs Arterial hypertensive vasculopathy
Veno-occlusive disease
Lymphatic disorders
Unclassified Conditions that do not clearly fit into specific category (i.e. end-stage disease, inadequate or non-diagnostic biopsy specimen)

Abbreviations: BPD=bronchopulmonary dysplasia; ILD=interstitial lung disease; SLE=systemic lupus erythematosis;

*

Includes examples of specific diagnoses classified within each category.

Adapted from [1] Deutsch et al, AJRCCM 2007.